Lung - Refresher 2021 is organized by American Society for Radiation Oncology (ASTRO).
Course opens: 03/31/2020
Course expires: 04/04/2024
Description :
The management of non-small cell lung cancer has undergone a major transformation in the last three years driven by the increasing use of immunotherapy as well as local ablative therapies in advanced-stage disease. Translation of these practices into community-based settings is important as overall survival in lung cancer has dramatically improved with the incorporation of improved treatment. This educational activity will help participants to better apply new treatment strategies so that patient outcomes can be enhanced.
Learning Objectives :
Upon completion of this activity, learners should be able to:
• Apply the increasing role of radiotherapy in advanced-stage lung cancer.
• Describe the instances when radiotherapy for the advanced-stage disease is not indicated
Available Credit:
1.50 Certificate of Attendance
This activity was designated for 1.50 AMA PRA Category 1 Credit™.
1.50 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved